Status:
COMPLETED
Sonographic 3D Measurement of Fetal Thymus May be Used to Predict the Small Baby in Pregnancy.
Lead Sponsor:
Karadeniz Technical University
Conditions:
Intrauterine Growth Restriction
Eligibility:
FEMALE
Brief Summary
The exact etiology of intrauterine growth restriction (IUGR) remains unclear but is known to involve immunologic/infectious factors. The thymus is one of the main organs involved in the development of...
Detailed Description
A signed informed consent form for voluntary participation in the study was provided by all the women. A record was made for each patient of age, gravida, parity, body mass index (BMI), and sonographi...
Eligibility Criteria
Inclusion
- Aged 18-35 years,
- Who presented at the polyclinic for routine antenatal follow-up at 15-24 weeks
- Had no complaints.
- Had normal renal, hepatic, and thyroid functions test results.
Exclusion
- Any known endocrinopathy,
- systemic disease,
- collagen disorder,
- hypercholesterolemia,
- hemoglobinopathy
- history of neoplasm,
- current or previous cardiovascular disease,
- the use of any drugs within the 3 months before the pregnancy,
- multiple pregnancy,
- current smoking,
- abnormal renal, hepatic, or thyroid function test results,
- the presence of any findings of fetal chromasomal or structural anomaly,
- refusal to participate in the study.
Key Trial Info
Start Date :
March 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2017
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05328453
Start Date
March 1 2016
End Date
March 1 2017
Last Update
April 14 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.